Riskpilot← Back to searchSign inGet full accessSTADA NORDIC ApS
APSActiveCVR 13902992Marielundvej 46AWholesale of pharmaceutical and medical goods · NACE 4646Est. 199046 employees
Revenue 2024
DKK 1B
+28% vs 2023
EBITDA margin
7.3%
-21% vs 2023
Equity ratio
45.4%
Financial strength
Net profit 2024
DKK 46,1M
-30% vs 2023
| Revenue | DKK 1B | +28% |
| EBITDA | DKK 75,7M | -21% |
| Net profit | DKK 46,1M | -30% |
| Total assets | DKK 642,6M | +24% |
| Equity | DKK 291,7M | +19% |
| Employees | 46 | — |
Legal name
STADA NORDIC ApS
CVR number
13902992
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. februar 1990
Share capital
DKK 1.200.000
Employees
46 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller af et bestyrelsesmedlem i forening med en direktør
Company purpose
Selskabets formål er at drive handel og fabrikation samt dertil knyttet virksomhed
Address
Marielundvej 46A
Phone
+4544859999
Email
mail@stada.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 224.498 | 264.564 | 240.527 | 271.070 | 292.176 | 369.644 | 494.625 | 462.793 | 677.719 | 808.742 | 1.033.292 |
| Staff expenses | -7.882 | -12.428 | -14.550 | -14.635 | -15.306 | -16.165 | -23.488 | -24.570 | -31.339 | -0 | -38.847 |
| EBITDA | 18.608 | 13.704 | 8.474 | 11.396 | 13.195 | 22.877 | 31.800 | 45.805 | 91.956 | 95.927 | 75.747 |
| Depreciation & amort. | -4.233 | -6.328 | -6.634 | -6.991 | -6.991 | -6.991 | -3.455 | -3.493 | -3.582 | -0 | -2.935 |
| EBIT | 14.375 | 7.376 | 1.841 | 4.406 | 6.205 | 15.886 | 28.346 | 42.312 | 88.374 | 95.927 | 72.812 |
| Net financials | -755 | -1.036 | -1.694 | -2.809 | -922 | -4.571 | -1.596 | -5.401 | -8.131 | -11.251 | -14.468 |
| Profit before tax | 10.142 | 5.670 | 147 | 1.596 | 5.282 | 11.315 | 26.750 | 36.911 | 80.243 | 84.675 | 58.344 |
| Tax | -0 | -0 | -27 | 390 | 948 | 2.462 | 5.817 | 8.083 | 17.560 | 18.319 | 12.216 |
| Net profit | 8.031 | 4.896 | 174 | 1.206 | 4.334 | 8.853 | 20.933 | 28.829 | 62.683 | 66.357 | 46.128 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 164.924 | 217.330 | 206.098 | 197.853 | 206.737 | 208.413 | 291.957 | 326.458 | 405.630 | 518.110 | 642.636 |
| Equity | 107.161 | 112.058 | 89.732 | 90.938 | 95.272 | 66.801 | 87.733 | 116.562 | 179.245 | 245.601 | 291.730 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 488 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 54.714 | 105.173 | 116.267 | 106.815 | 111.365 | 140.524 | 199.601 | 206.568 | 223.056 | 268.036 | 341.292 |
| Total debt | 54.714 | 105.173 | 116.267 | 106.815 | 111.365 | 141.012 | 199.601 | 206.568 | 223.056 | 268.036 | 341.292 |
EBITDA margin
7.3%
This company
15.8%
Market median
-54% vs market
20142024
Equity ratio
45.4%
This company
38.2%
Market median
+19% vs market
20142024
Return on equity
15.8%
This company
18.4%
Market median
+14% vs market
20142024
Net profit margin
4.5%
This company
8.1%
Market median
-44% vs market
20142024
Asset turnover
1.61×
This company
1.12×
Market median
+44% vs market
20142024
Debt / equity
1.20×
This company
0.62×
Market median
-94% vs market
20142024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
VP Management | Management | 1990 | — | — |
IL Chief Executive Officer | Chief Executive Officer | 2006 | — | — |
HG Management | Management | 1990 | — | — |
ET | Audit | 1990 | — | — |
JH Chief Executive Officer | Chief Executive Officer | 2001 | — | — |
AK Management | Management | 1998 | — | — |
SS Management | Management | 1990 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 1998 | — | — | |
| Chairman | 2011 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 1998 | — | — | |
| Chairman | 2006 | — | — | |
| Board of Directors | 1990 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2009 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of STADA NORDIC ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Verner Pedersen | Management | 0 companies |
| Inge-Merete Larsen | Chief Executive Officer | 0 companies |
| Henning Gustav Klee | Management | 0 companies |
| Erik Tronborg Andersen | Audit | 0 companies |
| Johannes Henrices Adrianus Stols | Chief Executive Officer | 0 companies |
| Annalise Klee | Management | 0 companies |
| Susanne Saul Stakemann | Management | 0 companies |
| Dieter Günther Karl-Heinz Rudolph | Board of Directors | 0 companies |
| Luc Maurice Godelieva Slegers | Chairman | 0 companies |
| Berit Goldmann | Board of Directors | 0 companies |
| Wolfgang Alfred Jeblonski | Board of Directors | 0 companies |
| Rory Walter O'Riordan | Chairman | 0 companies |
| Per Emil Hasselbalch Stakemann | Board of Directors | 0 companies |